Cansortium Inc. (OTCMKTS:CNTMF – Get Rating) was the target of a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 8,200 shares, a decline of 85.9% from the November 15th total of 58,000 shares. Based on an average daily volume of 439,900 shares, the short-interest ratio is presently 0.0 days.

Cansortium Trading Down 5.7 %

CNTMF traded down $0.01 during trading hours on Monday, reaching $0.17. The company's stock had a trading volume of 27,425 shares, compared to its average volume of 211,045. Cansortium has a fifty-two week low of $0.13 and a fifty-two week high of $0.71. The business's 50-day moving average is $0.17 and its 200-day moving average is $0.18.

Wall Street Analyst Weigh In

Separately, BTIG Research initiated coverage on Cansortium in a report on Friday, October 28th. They issued a "buy" rating on the stock.

About Cansortium

Cansortium Inc, through its subsidiaries, produces and sells medical cannabis in the United States. The company engages in the cultivation, processing, retail, and distribution activities. Its medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, prerolls, cartridges, and edibles.

Read More

• Get a free copy of the StockNews.com research report on Cansortium (CNTMF)
• Three Small-Cap Biotech Stocks to Consider Now
• Two Blue Chip Health Companies The Institutions Are Buying
• What To Expect From The Q4 Earnings Reporting Season
• Here's What to Expect for the S&P 500 in 2023
• Can Bilibili be the Chinese Version of YouTube?

Receive News & Ratings for Cansortium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cansortium and related companies with MarketBeat.com's FREE daily email newsletter.